chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Fever, chill, headache, vertigo, leg muscles pain/ weakness/ stiffness and not able to walk for 3 days post vaccination. Patient is slowly gaining motility but still vertigo and headache to now.
Adult dosage of Pfizer was given to pediatric patient. When I examined the card I assumed patient was over the age of twelve years old due to previous Pfizer dose only saying  Pfizer on the card. Patient waited 15 minutes in lobby and no adverse reaction occurred.
Headache, Cold sweats, flushing, weakness, painful joints, extreme fatigue starting 2 hours post vaccine lasted 24 hours All symptoms have subsided except for worsening constant headache and joint pain more than 2 weeks post vaccine.
pt stated that she got really warm within a couple of minutes of getting the vax.   Pt got tightness under eyes, checks, and inside her mouth.  She had some pinching feelings in her chest which she said this may be acid reflux. Her right leg was hurting near her ankle and foot.  Nurse at vax site checked her stats and everything was normal.  She was given Benadryl.  These symptoms subsided.  After getting home she had some tickling in her throat.  Pt only has soreness  and redness in her left arm today.
Patient got the second dose in 3 weeks instead of 4 weeks apart; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a health care professional and describes the occurrence of INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (Patient got the second dose in 3 weeks instead of 4 weeks apart) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On 12-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 03-May-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 03-May-2021,  after starting mRNA-1273 (Moderna COVID-19 Vaccine), the patient experienced INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (Patient got the second dose in 3 weeks instead of 4 weeks apart). At the time of the report, INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (Patient got the second dose in 3 weeks instead of 4 weeks apart) had resolved. Not Provided      For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medications were reported.  No treatment information was provided.
After receiving 5 pediatric vaccines at 11:00, client stopped breathing, color bright red, then at. Went pale, and had weak cry. Client did not regain normal color or cry, 911 called, at hospital. Upon vasovagal s/s, nurse placed on back to promote circulation abd stimulated client by rubbing soles, undressing and changing positions keeping supine.
Client reports onset on rash/hives on 12/14/11. Reports she went to the doctor and is being treated with steroids.
Thursday, July 7th, I picked him up from school and walked him home.  He only ate part of his fig bar because he said it didn't taste good.  He also didn't want any dinner which is very rare.  He said that his tummy hurt.  I assumed it was the fig bar.  He finally ate 2 bites of soup but didn't want any more.  When I brushed his teeth I only brushed half  because he said it hurt.  He went to bed pretty easily but he looked so exhausted.  About 10:00pm he woke up and he was sweaty and clammy.  He wasn't feeling well and seemed a bit delirious because he didn't realize I was really in the room with him as I rocked him.  He cried about his tummy hurting and pointed to below his belly button.  He cried and said he wanted to go home.  He didn't realize he was home.  The next morning he slept in which is rare.  He just wanted to keep sleeping but he needed to go to school.  He didn't want breakfast but ate some of a banana.  He said it didn't taste good.  I gave him a COVID-19 test and it was negative.  He said his throat hurt and he said yes.  He was a bit irritable and bit whiny and then he'd be fine.  After a little bit he seemed better because he was playing in the floor and went to school.  At school he ate breakfast, lunch and afternoon snack and had no problems.  When he got home he seemed back to normal.  After I talked to the nurse mid morning, I had realized that he had a small red rash (oval size) on his arm.  It was at the injection site.  I messaged the doctor to let them know.
pt recvd vax 5OCT94 & 15OCT94 exp a scratchy throat, intermittent bilat ear pain, lower back pain, & h/a;16OCT94, fever of 100.6;17OCT94 temp 100.4;18OCT94 awoke w/scattered red rash which looked like measles on face which spread to abd
Narrative:  74yo male died on 12/20/21. Cause of death is unknown. pt had history of: E55.9 Vitamin D deficiency (SCT34713006) I10. Hypertension (SCT 38341003) E11.9 Type 2 diabetes mellitus (SCT 44054006) I25.10 Coronary atherosclerosis (SCT 443502000) J44.9 Chronic obstructive lung disease (SCT 13645005) M19.91 Osteoarthritis (SCT 396275006) E78.00 Hyperlipidemia (SCT 55822004) Pt had received covid vaccines on 2/26/21 & 3/26/21. Likely pt's death is not related to covid vaccines given pt's advanced age, comorbidies, and long length of time between death & date of vaccine administrations.
Sore muscle in left elbow. Feels a bit like joint pain. Noticed it within about 15min after injection. Not terribly painful, but sore. Notice mostly in morning or when doing activity that requires movement of elbow. Still similar amount of pain since day of injection.
Metallic taste in mouth shortly after getting shot, and a raw spot feeling inside upper lip on right side.
feels so sick she wants to die; everything hurts so bad; back is really hurting; she's so hot; shaking so hard; feels really crappy; arm is so sore she can hardly touch it; This spontaneous case was reported by a consumer and describes the occurrence of ILLNESS (feels so sick she wants to die), PAIN (everything hurts so bad), BACK PAIN (back is really hurting), FEELING HOT (she's so hot) and TREMOR (shaking so hard) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included No adverse event.    On 08-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced ILLNESS (feels so sick she wants to die), PAIN (everything hurts so bad), BACK PAIN (back is really hurting), FEELING HOT (she's so hot), TREMOR (shaking so hard), PERSONALITY DISORDER (feels really crappy) and PAIN IN EXTREMITY (arm is so sore she can hardly touch it). At the time of the report, ILLNESS (feels so sick she wants to die), PAIN (everything hurts so bad), BACK PAIN (back is really hurting), FEELING HOT (she's so hot), TREMOR (shaking so hard), PERSONALITY DISORDER (feels really crappy) and PAIN IN EXTREMITY (arm is so sore she can hardly touch it) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.  Treatment products included Tylenol.
Developed Vertigo next day. Vertigo lasted 4 days.; Achy and sore, whole right side sore, from ear to hip; Dizziness; Exhaustion/tired. Exhaustion lasted 6 days, still wiped out.; Nausea; This is a spontaneous report from a contactable consumer, the patient. A 60-year-old male patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0161) via an unspecified route of administration in the right arm on 14Apr2021 at 10:45 (at the age of 60-years-old) as a single dose for COVID-19 immunisation. Medical history included high blood pressure, diabetes and high cholesterol. The patient had known allergies to potatoes. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient received unspecified medications within two weeks of vaccination. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN6208) via an unspecified route of administration in the right arm on 11Mar2021 at 10:00 (at the age of 60-years-old) as a single dose for COVID-19 immunisation. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 14Apr2021 at 19:00, the patient experienced tired, achy and sore, whole right side sore from ear to hip, dizziness, exhaustion and nausea. On 15Apr2021, the patient experienced vertigo that lasted 4 days. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the event vertigo was resolved on 19Apr2021, after the duration of 4 days. The clinical outcome of the events tired, achy and sore, whole right side sore from ear to hip, dizziness, exhaustion and nausea was resolving at the time of this report.   No follow-up attempts are needed. No further information is expected.
Had chest pain, dizziness, arm pain, neck and jaw pain, nausea and pressure on the chest. Thought it was heart related and went to the ER -- kept overnight for observation but they could find no heart-related cause.
Not feeling good; This case was reported by a physician via sales rep and described the occurrence of feeling unwell in a 59-year-old male patient who received Herpes zoster (Shingrix) for prophylaxis.   Previously administered products included Shingrix with an associated reaction of malaise (for the tolerance of the 1st dose, refer linked case US2022AMR160021).   On an unknown date, the patient received the 2nd dose of Shingrix. On an unknown date, unknown after receiving Shingrix, the patient experienced feeling unwell. Rechallenge with Shingrix was positive. On an unknown date, the outcome of the feeling unwell was recovered/resolved.   The reporter considered the feeling unwell to be related to Shingrix.     Linked case(s) involving the same patient:  US2022AMR160021   Additional Information: GSK Receipt Date: 02-NOV-2022 Reporter's Comment: Reporter was the patient. He reported not feeling good for 1 to 2 days after immunization with Shingrix. The patient was asked if reported since he was a vaccine expert, he stated that he had not and these events are expected with Shingrix vaccine. The reporter did not consent to follow up.; Sender's Comments:  US-GSK-US2022AMR160021:same patient, 1st dose
Stomach uncomfortable; Vomiting; Had cough that would not quit; This is a spontaneous report from a contactable consumer (patient). This 79-year-old female patient received first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE) (Lot # EL3246), via an unspecified route of administration on 21Jan2021 at single dose on the left arm for COVID-19 immunization. The patient's medical history and concomitant medications were none. Patient took COVID 19 vaccine was because of her age group and risks. The patient experienced stomach uncomfortable, vomiting and had cough that would not quit, all on 21Jan2021. Clinical course reported as follow: patient stated she had yesterday that got first COVID vaccine. Stated that she had it at 9:00PM. Stated that she was fine until 3:30. Stated that her stomach was uncomfortable. Stated that at 7:00 she started vomiting for 4-5 hours. Had a cough that would not quit that started at 7PM. Patient stated that her stomach and cough resolved at midnight. Stated that she recovered completely from both. No treatment received. Outcome of the events was recovered on 21Jan2021. No investigation assessment.
Retrosectively, mom remembers an acute disinterest in booles/printing to pictures three days after vaccines. Recently he has been dx'ed with autism, mild ?. Previous to vaccination we had concerns to speech.
I got the second vaccine and I had severe abdominal pain and I went to the UTI and they sent me to the ER and they taught it was appendicitis but it was not and they sent me home and it turned out to be COVID again and I had fever and severe abdominal pain.
Initial unsolicited report received from Consumer on 16-Feb-2016. This case involves a 14-year-old female patient who was vaccinated with an intramuscular dose of TETANUS TOXOID (manufacturer: unknown and batch number was not reported) in left deltoid in 1968 on unspecified date. Illness at the time of vaccination was reported as none. Pre-existing physician diagnosed allergies, birth defects; medical conditions were reported as none. Other medical history and concomitant medications were not reported. In 1968 on unspecified date, after vaccination, patient had swelling and redness in the arm at injection site. She also had a fever. Lab test and corrective treatments were not reported. Patient was not recovered from the event. Documents held by sender: none.
Chills and violent shaking at 7:30pm temp 99.0. Gave 2 Tylenol. At 10:00 temp 101.6 then went to 101.7 and gave Ibuprofen 400mg. At 11:00 pm temp down to 99.7 and fell asleep. 9:00 a temp 97.5.   Had no appetite all day 2/26 injection site red, swollen and bad pain. When fever went high had no mobility and could not sit up to take meds. Next day tired and listless.
Patient received a more concentrated dose of the vaccine. 1.3 ml of diluent was added to the vaccine instead of 1.8ml. Patient has not reported any adverse reactions.
Pediatric dose was given to adults mistakenly; No adverse event; This spontaneous case was reported by an other health care professional and describes the occurrence of WRONG PRODUCT ADMINISTERED (Pediatric dose was given to adults mistakenly) and NO ADVERSE EVENT (No adverse event) in an adult patient of an unknown gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. AR5186C) for COVID-19 prophylaxis.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced WRONG PRODUCT ADMINISTERED (Pediatric dose was given to adults mistakenly) and NO ADVERSE EVENT (No adverse event). At the time of the report, WRONG PRODUCT ADMINISTERED (Pediatric dose was given to adults mistakenly) and NO ADVERSE EVENT (No adverse event) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessment was provided for WRONG PRODUCT ADMINISTERED (Pediatric dose was given to adults mistakenly).    No concomitant medication was reported.  It was reported patient received the error dose with instruction to re-vaccinate 2 months from the initial error doses.  This case was created for patient no. 37 out of 104 cases.  No treatment information was provided.
Patient felt weak and developed generalized rash on 10/21/2020 AM.  Patient's husband text patient's sign and symptoms and photo of skin rash.  Benadryl and Medrol dose pack oral were prescribed.  Patient had a vasovagal event at home 10/21/2020 in the afternoon after taken first 4mg  Medrol dose.  Patient had a video telemedicine with provider in the afternoon.  Patient was alert and orient sitting in the house.  Patient subsequently was brought to local ER by husband in the early evening, and received epinephrin, diphenhydramine  and methylprednisonlone sod succ (SOLUMEDROL) and IV fluid.  Patient discharged home with ER diagnosis acute allergic reaction, initial enounter and syncope and collapse.
Pt. had hx of SOB prior to vaccination and Dx with hear failure Woke up day after vaccination with being very tired. Admitted to hospital with UTI, Sepsis
Swollen Lymph Node in injection arm; horrible headache; muscle aches; fever; chills; nausea; This is a spontaneous report from a contactable consumer, the patient. A 43-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN6200) via an unspecified route of administration in the left arm on 07Apr2021 at 12:45 (at the age of 43-years-old) as a single dose for COVID-19 immunisation. Medical history included anxiety and migraine. The patient had no known allergies to medications, food, or other products. Concomitant medications taken within two weeks prior to vaccination included sertraline (MANUFACTURER UNKNOWN), bromelains, calcium carbonate, camellia sinensis leaf, glucosamine hydrochloride, zingiber officinale root (REPLENEX) (reported as Replenx), Pre/Probiotic and ibuprofen (MANUFACTURER UNKNOWN), all from unknown date for unknown indication. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN6207) via an unspecified route of administration in the right arm on 17Mar2021 at 12:45 (at the age of 43-years-old) as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 08Apr2021 at 07:00 the patient experienced swollen lymph node in injection arm, horrible headache, muscle aches, fever, chills, nausea. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department. No therapeutic measures were taken as a result of the events. The clinical outcome of the events swollen lymph node in injection arm, horrible headache, muscle aches, fever, chills, nausea was not resolved at the time of this report.   No follow-up attempts are needed. No further information is expected.
Legs from the knees down were itching horribly; Such an itchy itchy spot; This spontaneous case was reported by a consumer and describes the occurrence of PRURITUS (Legs from the knees down were itching horribly) and VACCINATION SITE PRURITUS (Such an itchy itchy spot) in a 52-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 016M20A and 004M20A) for COVID-19 vaccination.     No medical history was provided by the reporter.  Concomitant products included CETIRIZINE for an unknown indication.   On 03-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 03-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. In August 2021, the patient experienced PRURITUS (Legs from the knees down were itching horribly). On an unknown date, the patient experienced VACCINATION SITE PRURITUS (Such an itchy itchy spot). The patient was treated with HYDROCORTISONE for Adverse event, at an unspecified dose and frequency and DIPHENHYDRAMINE HYDROCHLORIDE (BENADRYL [DIPHENHYDRAMINE HYDROCHLORIDE]) for Adverse event, at an unspecified dose and frequency. At the time of the report, PRURITUS (Legs from the knees down were itching horribly) and VACCINATION SITE PRURITUS (Such an itchy itchy spot) had resolved.            Other concomitant product use included nasal spray.  Other treatment product use included OTC medicine.  It was reported that the medications that the patient used to treat adverse event didn't worked and those  adverse events experienced by her went away eventually.   This case was linked to MOD-2021-368798 (Patient Link).
Dermatological rash & itching about forehead, scalp, face, back of head; diarrhea, fatigue
This spontaneous report was received from a registered nurse (R.N.) and refers to a male patient of current age 17 years. No medical history and concurrent conditions of the patient was reported. On 13-AUG-2015, the patient was vaccinated with first dose of GARDASIL injection of strength 120 Y (lot # K016966 and expiry date: 10-MAY-2017) subcutaneously in the right arm. No concomitant medications were reported. The R.N. reported that in 2015 (dates unspecified), the patient experienced unspecified hives following the vaccination. The patient was not treated for the adverse event and did not sought any medical attention. The patient recovered from the hives in 2015 (exact dates unspecified). No product quality complaint (PQC) was filed. No further information was provided. Additional information has been requested.
Patient initially presented with L leg weakness. Patient left-sided weakness secondary to acute ischemic CVA likely right MCA.  Patient noted to have acute on chronic normocytic iron deficiency anemia.     Patient remained hemodynamically stable throughout her stay.  Her discharge was delayed due to  Asymptomatic COVID-19 infection positive on 2/10/22 (5 days after admission)
1. Severe pain at time of injection 2. Local redness noted same day 3. Development over time of knot at injection site 06/08/2011 4. Increase in size of knot 06/27/2011 5. Pus drained from site 07/01/2011 6. Referred for ID consultation 07/11/011--diagnosis sterile abscess vs infected hematoma
HEADACHE, CHILLS, FATIGUE, BODY ACES AND SORE ARM
pt recv vax 29SEP97 & the next day pt exp redness (60mm), swelling, warmth & inflammation @ the inj site;
EMPLOYEE REPORTED  AT 7:OOPM  ON 7/12/2020 SHE STRARTED SWEATING, CHILLS, FEVER, SORENESS IN RIGHT ARM   SYMPTOMS LASTED UNTIL 1:00AM THIS MORNING. EMPLOYEE CONTINUES TO FEEL NAUSEA
This case was reported by a consumer via call center representative and described the occurrence of injection site pain in a 61-year-old female patient who received SHINGRIX for prophylaxis. On 18th April 2018, the patient received the 1st dose of SHINGRIX (intramuscular). On an unknown date, less than a year after receiving SHINGRIX, the patient experienced injection site pain. On an unknown date, the outcome of the injection site pain was recovered/resolved. It was unknown if the reporter considered the injection site pain to be related to SHINGRIX. Additional details were reported as follows: The patient received SHINGRIX on left arm. The patient experienced pain at injection site that lasted for about total of 3 weeks. The patient gave permission to contact her physician. The patient would follow up with her physician in a week from the date of reporting. No further details were provided. This case has been linked with case US2018GSK135535, reported by the same reporter (same patient for 2nd dose).